Hypersensitivity reactions associated with fidaxomicin use

Clinical Infectious Diseases

Volumn 58, Issue 4, 2014, Pages 537-539

  Iarikov, Dmitri E ^a   Alexander, John ^a   Nambiar, Sumathi ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

adverse reactions; fidaxomicin; hypersensitivity

Indexed keywords

FIDAXOMICIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HYPERSENSITIVITY; HUMAN; MAXIMUM PLASMA CONCENTRATION; PRESCRIPTION; PRIORITY JOURNAL; SKIN BIOPSY; ADULT; AGED; CLOSTRIDIUM INFECTIONS; DIARRHEA; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE;

ADULT; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84893331949     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit719     Document Type: Article

References (4)

1. DIFICID label. Available at: http://www.accessdata.fda.gov/drugsatfda- docs/label/2013/201699s004lbl.pdf. Accessed 20 September 2013.
2. Mucci T, Davis-Lorton M. Purpuric drug eruption secondary to fidaxomicin. Infect Dis Clin Prac 2013. http://journals.lww.com/infectdis/Abstract/ publishahead/Purpuric-Drug-Eruption-Secondary-to-Fidaxomicin. 99524.aspx.
3. Bosse D, Lemire C, Ruel J, Cantin AM, Menard F, Valiquette L. Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection. Infection 2013; 41:579-82.
4. Osawa R, Kaka AS. Maculopapular rash induced by oral vancomycin. Clin Infect Dis 2008; 47:860-1. BRIEF